Cargando…

Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease

BACKGROUND: Cardiovascular disease (CVD) and cancer share many common risk factors; patients with CVD also may be at risk of developing cancer. OBJECTIVES: The aim of this study was to derive and externally validate prediction models for the estimation of lifetime and 10-year risk for total, colorec...

Descripción completa

Detalles Bibliográficos
Autores principales:	van ’t Klooster, Cilie C., Ridker, Paul M., Cook, Nancy R., Aerts, Joachim G.J.V., Westerink, Jan, Asselbergs, Folkert W., van der Graaf, Yolanda, Visseren, Frank L.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352343/ https://www.ncbi.nlm.nih.gov/pubmed/34396248 http://dx.doi.org/10.1016/j.jaccao.2020.07.001

Ejemplares similares

The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study
por: van’t Klooster, Cilie C, et al.
Publicado: (2019)

Multifocal cardiovascular calcification in patients with established cardiovascular disease; prevalence, risk factors, and relation with recurrent cardiovascular disease
por: van 't Klooster, Cilie C., et al.
Publicado: (2020)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

Lifestyle changes and kidney function: A 10‐year follow‐up study in patients with manifest cardiovascular disease
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
por: Westerink, Jan, et al.
Publicado: (2011)

Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?
por: Berkelmans, Gijs F. N., et al.
Publicado: (2020)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease
por: van de Woestijne, Anton P., et al.
Publicado: (2014)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
por: Selvarajah, Sharmini, et al.
Publicado: (2011)

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort
por: Sharif, Shahnam, et al.
Publicado: (2019)

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
por: Verhagen, Sandra N, et al.
Publicado: (2011)

Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study
por: Østergaard, Helena Bleken, et al.
Publicado: (2022)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
por: Schrover, Ilse M, et al.
Publicado: (2018)

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

Estimating treatment effects for individual patients based on the results of randomised clinical trials
por: Dorresteijn, Johannes A N, et al.
Publicado: (2011)

End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease
por: Kranendonk, Mariëtte EG, et al.
Publicado: (2014)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Impact of a Patient’s Baseline Risk on the Relative Benefit and Harm of a Preventive Treatment Strategy: Applying Trial Results in Clinical Decision Making
por: de Vries, Tamar I., et al.
Publicado: (2021)

Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Immunological profiling as a means to invigorate personalized cancer therapy
por: Hegmans, Joost PJJ, et al.
Publicado: (2013)

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
por: Dorresteijn, Johannes A N, et al.
Publicado: (2013)

Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data
por: Groenhof, T Katrien J, et al.
Publicado: (2020)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
por: Belderbos, Robert A., et al.
Publicado: (2019)

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease
por: Jagt, Vivianne L., et al.
Publicado: (2022)

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes
por: Sharif, S., et al.
Publicado: (2019)

Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research
por: Arsyad, Dian Sidik, et al.
Publicado: (2022)

The relationship between walking speed and changes in cardiovascular risk factors during a 12-day walking tour to Santiago de Compostela: a cohort study
por: Bemelmans, Remy H H, et al.
Publicado: (2012)

Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
por: Cupido, Arjen J., et al.
Publicado: (2022)

The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk
por: Heidemann, Britt E, et al.
Publicado: (2023)

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
por: Brugts, J J, et al.
Publicado: (2009)

The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy
por: de Mol, Mark, et al.
Publicado: (2016)

Low‐Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex Specific
por: Cupido, Arjen J., et al.
Publicado: (2022)

The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, Indonesia
por: Arsyad, Dian Sidik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtt4s33jr4tb7gr6i433b6kt93